NH8-22216-40329
2 vaccinations
1 coded response
20 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 074 / NJ
- Registered
- 2021-06-17
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-06-16
Dose 1 — Pfizer-BioNTech
-
2021-06-17
Registered in v-safe
-
2021-06-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-06-18
- 2021-06-19
- 2021-06-20
- 2021-06-21
- 2021-06-23
- 2021-06-30
-
2021-07-07
Dose 2 — Pfizer-BioNTech
- 2021-07-07
- 2021-07-08
-
2021-07-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-07-10
- 2021-07-12
- 2021-07-13
- 2021-07-14
-
2021-07-21
Survey response — day 14, dose 2MedDRA: Cough, Oropharyngeal pain, Paranasal sinus discomfort, Respiratory tract congestion — Feeling: GoodFree text: Congested, sinus pressure, sore throat, coughMedDRA releases: 2024-11 · check-in free text available
- 2021-07-28
- 2021-08-05
- 2021-08-11
- 2021-08-20
- 2021-10-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-16 | Pfizer-BioNTech | |
| 2 | 2021-07-07 | Pfizer-BioNTech | No |
Free text
Release 9 — day 14, dose 2
Symptoms: Congested, sinus pressure, sore throat, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release